marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-05-2024
BioCryst Pharmaceuticals Operating Income 2011-2024 | BCRX
Annual Operating Income BioCryst Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -104 M | -148 M | -178 M | -175 M | -99.5 M | -94.2 M | -57.4 M | -48.6 M | -39.4 M | -45.8 M | -30.7 M | -33.9 M | -49.6 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -30.7 M | -178 M | -84.9 M |
Quarterly Operating Income BioCryst Pharmaceuticals
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 7.69 M | 8.76 M | -14.5 M | - | -11.9 M | -20.7 M | -28.4 M | - | -17.4 M | -34.7 M | -50 M | - | -44.6 M | -29.6 M | -51.4 M | - | -42.9 M | -38.5 M | -41 M | - | -35.1 M | -34.9 M | -29.3 M | - | -28.5 M | -18.3 M | -22.2 M | - | -13.3 M | -15.5 M | -10.7 M | - | -9.24 M | -12.1 M | -19 M | - | -13.2 M | 5.34 M | -14.4 M | - | -11.6 M | -11.6 M | -7.39 M | - | -6.92 M | -12.1 M | -5.32 M | - | -8.02 M | -10.2 M | -5 M | - | -12.8 M | -14.2 M | -11.5 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 8.76 M | -51.4 M | -19 M |